Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

The cash injection comes amid a period of gathering momentum for Jnana, which has just started clinical testing of its first in-house candidate JNT-517, billed as a potential first-in-class ...

Additionally, UBS has factored in JNT-517, a drug from the pipeline of Jnana Therapeutics, which was acquired by Otsuka. The new price target of JPY10,000.00 is derived from the net present value ...

Hyderabad: Captain Rahul Singh scored 68 and added 95 with Abhirath Reddy (39) for the second wicket as Hyderabad set Chhattisgarh a daunting target of 517 runs on the third day of the All India ...

Additionally, UBS has factored in JNT-517, a drug from the pipeline of Jnana Therapeutics, which was acquired by Otsuka. The new price target of JPY10,000.00 is derived from the net present value (NPV ...